Randomized Open-Label Trial to Evaluate the Effectiveness of Diet Management With a Losartan Titration Regimen Versus Losartan Titration Regimen Alone on Blood Pressure Reduction in Hypertensives.

Trial Profile

Randomized Open-Label Trial to Evaluate the Effectiveness of Diet Management With a Losartan Titration Regimen Versus Losartan Titration Regimen Alone on Blood Pressure Reduction in Hypertensives.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 May 2017

At a glance

  • Drugs Losartan (Primary) ; Calcium channel antagonists; Hydrochlorothiazide
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms SAALT
  • Sponsors Merck & Co
  • Most Recent Events

    • 05 May 2010 Actual end date (1 Jan 2010) added as reported by ClinicalTrials.gov record.
    • 05 May 2010 Actual patient number (974) added as reported by ClinicalTrials.gov.
    • 05 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top